A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions.

Bossi, Antonio C; Forloni, Franco; Colombelli, Paolo L

A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions.

Bossi, Antonio C; Forloni, Franco; Colombelli, Paolo L.

Afiliação

Bossi AC; Endocrine Unit-Diabetes Regional Center, Treviglio, BG, Italy. antonio_bossi@asst-bgovest.it.
Forloni F; Endocrine Unit-Diabetes Regional Center, Treviglio, BG, Italy.
Colombelli PL; Internal Medicine Division, ASST Bergamo Ovest, Treviglio, BG, Italy.

Diabetes Ther ; 11(12): 3007-3009, 2020 Dec.

Article em En | MEDLINE | ID: mdl-33052537

Palavras-chave

Pleiotropic effects of SGLT2-i; SGLT2-i in COVID-19; Sodiumglucose cotransporter 2 inhibitors (SGLT2-i)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Diabetes Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google